lactic acid has been researched along with Peritoneal Neoplasms in 11 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisplatin incorporated into polylactic acid/polyethylene glycol acid blend polymeric microspheres was prepared as a dosage (CDDP-MS) by solvent evaporation method in oil-in-oil emulsion system." | 5.29 | [Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats]. ( Aiko, T; Hatate, Y; Kumanohoso, T; Nakamura, K; Natsugoe, S; Nedachi, M; Shimada, M; Tokuda, K; Uemura, Y; Yamada, K; Yoshizawa, H, 1996) |
| "However, the role of MCTs in gastric cancer (GC) is not fully understood." | 1.43 | MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. ( Ahn, SM; Chang, WJ; Cho, JH; Jung, KS; Kang, WK; Kim, HS; Kim, KM; Kim, ST; Kim, SY; Lee, I; Lee, J; Lee, JY; Lee, S; Lim, HY; Lim, SH; Park, JO; Park, SH; Park, YS; Song, HN; Yoo, KH, 2016) |
| "Micro- and nanoparticle formulations are widely used to improve the bioavailability of low solubility drugs." | 1.40 | Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis. ( Fan, R; Guo, G; Han, B; Luo, Y; Peng, X; Wang, Y; Wu, M; Zheng, Y; Zhou, L, 2014) |
| "As in ovarian cancer cells, increased metabolic activity and glucose concentration has been linked to aggressiveness of cancer." | 1.39 | Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells. ( Ben, W; Dong, L; Guan, Y; Huang, Y; Lu, M; Ning, N; Wang, Y; Yang, Y; Yuan, J; Zhang, D, 2013) |
| "Cisplatin incorporated into polylactic acid/polyethylene glycol acid blend polymeric microspheres was prepared as a dosage (CDDP-MS) by solvent evaporation method in oil-in-oil emulsion system." | 1.29 | [Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats]. ( Aiko, T; Hatate, Y; Kumanohoso, T; Nakamura, K; Natsugoe, S; Nedachi, M; Shimada, M; Tokuda, K; Uemura, Y; Yamada, K; Yoshizawa, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, D | 1 |
| Wang, Y | 2 |
| Dong, L | 1 |
| Huang, Y | 1 |
| Yuan, J | 1 |
| Ben, W | 1 |
| Yang, Y | 1 |
| Ning, N | 1 |
| Lu, M | 1 |
| Guan, Y | 1 |
| Zou, L | 1 |
| Yi, T | 1 |
| Song, X | 1 |
| Li, S | 1 |
| Wei, Y | 1 |
| Zhao, X | 1 |
| Fan, R | 2 |
| Han, B | 1 |
| Luo, Y | 1 |
| Zhou, L | 2 |
| Peng, X | 1 |
| Wu, M | 1 |
| Zheng, Y | 1 |
| Guo, G | 2 |
| Tong, A | 1 |
| Li, X | 1 |
| Gao, X | 1 |
| Mei, L | 1 |
| Zhang, X | 1 |
| You, C | 1 |
| Lee, JY | 1 |
| Lee, I | 1 |
| Chang, WJ | 1 |
| Ahn, SM | 1 |
| Lim, SH | 1 |
| Kim, HS | 1 |
| Yoo, KH | 1 |
| Jung, KS | 1 |
| Song, HN | 1 |
| Cho, JH | 1 |
| Kim, SY | 1 |
| Kim, KM | 1 |
| Lee, S | 1 |
| Kim, ST | 1 |
| Park, SH | 1 |
| Lee, J | 1 |
| Park, JO | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Battista, MJ | 1 |
| Goetze, K | 1 |
| Schmidt, M | 1 |
| Cotarelo, C | 1 |
| Weyer-Elberich, V | 1 |
| Hasenburg, A | 1 |
| Mueller-Klieser, W | 1 |
| Walenta, S | 1 |
| Tokuda, K | 2 |
| Natsugoe, S | 2 |
| Shimada, M | 2 |
| Kumanohoso, T | 2 |
| Yoshizawa, H | 2 |
| Uemura, Y | 1 |
| Hatate, Y | 2 |
| Nakamura, K | 2 |
| Yamada, K | 2 |
| Nedachi, M | 1 |
| Aiko, T | 1 |
| Baba, M | 1 |
| Takao, S | 1 |
| Aikou, T | 1 |
| Hagiwara, A | 1 |
| Sakakura, C | 1 |
| Shirasu, M | 1 |
| Yamasaki, J | 1 |
| Togawa, T | 1 |
| Takahashi, T | 1 |
| Muranishi, S | 1 |
| Hyon, S | 1 |
| Ikada, Y | 2 |
| Kanda, T | 1 |
| Sakamoto, M | 1 |
| Kubo, T | 1 |
| Maruyama, Y | 1 |
| Ike, O | 1 |
| Shimizu, Y | 1 |
| Watanabe, S | 1 |
| Natsume, T | 1 |
| Wada, R | 1 |
| Hyon, SH | 1 |
| Hitomi, S | 1 |
11 other studies available for lactic acid and Peritoneal Neoplasms
| Article | Year |
|---|---|
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Topics: Animals; Benzylidene Compounds; Biological Transport; Cell Line, Tumor; Cell Movement; Cell Prolifer | 2013 |
Efficient inhibition of intraperitoneal human ovarian cancer growth by short hairpin RNA targeting CD44.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hyaluronan Receptors; Lact | 2014 |
Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxe | 2014 |
Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.
Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cathelicidins; Cell Line | 2015 |
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; F | 2016 |
Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study.
Topics: Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Disease Progression; Energy Metabolism; Feas | 2016 |
[Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats].
Topics: Animals; Cisplatin; Delayed-Action Preparations; Drug Delivery Systems; Emulsions; Lactic Acid; Micr | 1996 |
Design and testing of a new cisplatin form using a base material by combining poly-D,L-lactic acid and polyethylene glycol acid against peritoneal metastasis.
Topics: Animals; Chemistry, Pharmaceutical; Cisplatin; Injections, Intraperitoneal; Lactic Acid; Male; Micro | 1998 |
Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice.
Topics: Animals; Biocompatible Materials; Colonic Neoplasms; Fluorouracil; Injections, Intraperitoneal; Lact | 1998 |
[Studies on a slow releasing anticancer agent for prevention of peritoneal recurrence of advanced gastrointestinal carcinomas (clinical study)].
Topics: Delayed-Action Preparations; Duodenal Neoplasms; Fluorouracil; Humans; Infusions, Parenteral; Lactat | 1992 |
Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) microspheres.
Topics: Animals; Biodegradation, Environmental; Delayed-Action Preparations; Diffusion; Doxorubicin; In Vitr | 1991 |